HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Liwu Fu Selected Research
Liwu Fu Research Topics
Disease
67
Neoplasms (Cancer)
03/2024 - 04/2004
13
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2023 - 09/2015
5
Lung Neoplasms (Lung Cancer)
01/2021 - 08/2015
5
Breast Neoplasms (Breast Cancer)
09/2017 - 11/2010
3
Neoplasm Metastasis (Metastasis)
02/2023 - 01/2010
3
Carcinogenesis
01/2022 - 01/2019
3
Esophageal Squamous Cell Carcinoma
01/2018 - 06/2014
3
Leukemia
01/2018 - 01/2016
2
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2021
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 05/2011
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2018
1
Inflammation (Inflammations)
01/2023
1
Papillary Thyroid Cancer
01/2020
1
Adenocarcinoma
01/2019
1
Type 2 Diabetes Mellitus (MODY)
11/2017
1
Acute Promyelocytic Leukemia
09/2017
1
Retinoblastoma (Glioblastoma, Retinal)
01/2017
Drug/Important Bio-Agent (IBA)
14
ATP-Binding Cassette Transporters (ABC Transporters)
IBA
01/2024 - 01/2014
14
Adenosine Triphosphate (ATP)
IBA
01/2024 - 01/2014
10
Proteins (Proteins, Gene)
FDA Link
01/2021 - 11/2010
8
Biomarkers (Surrogate Marker)
IBA
01/2024 - 01/2013
8
Tyrosine Kinase Inhibitors
IBA
12/2022 - 09/2015
6
Immune Checkpoint Inhibitors
IBA
03/2024 - 01/2020
6
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
12/2019 - 11/2010
5
ErbB Receptors (EGF Receptor)
IBA
12/2022 - 09/2015
3
MicroRNAs (MicroRNA)
IBA
01/2024 - 01/2019
3
osimertinib
IBA
12/2022 - 01/2016
3
Oncogene Proteins (Oncogene Protein)
IBA
01/2022 - 04/2016
3
multidrug resistance-associated protein 1
IBA
09/2017 - 11/2010
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2013 - 11/2010
2
Circular RNA
IBA
01/2024 - 01/2020
2
Cytokines
IBA
01/2023 - 04/2016
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2022 - 05/2019
2
Conditioned Culture Media
IBA
01/2021 - 01/2010
2
B7-H1 Antigen
IBA
01/2021 - 01/2020
2
Antineoplastic Agents (Antineoplastics)
IBA
06/2020 - 01/2014
2
Drug Combinations
IBA
01/2020 - 01/2018
2
Calcium
IBA
01/2019 - 01/2018
2
ceritinib
IBA
01/2018 - 12/2015
2
Anaplastic Lymphoma Kinase
IBA
01/2017 - 12/2015
2
Adenosine Triphosphatases (ATPase)
IBA
01/2017 - 08/2015
2
Antiviral Agents (Antivirals)
IBA
02/2016 - 10/2014
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2015 - 10/2012
2
Topotecan (Hycamtin)
FDA Link
Generic
08/2015 - 01/2015
1
Chimeric Antigen Receptors
IBA
03/2024
1
Untranslated RNA (Noncoding RNA)
IBA
01/2024
1
Prebiotics
IBA
04/2023
1
Integrins
IBA
02/2023
1
lazertinib
IBA
03/2022
1
adagrasib
IBA
01/2022
1
F-Box Proteins
IBA
01/2022
1
mirdametinib
IBA
10/2021
1
Small Interfering RNA (siRNA)
IBA
10/2021
1
Aldehyde Dehydrogenase
IBA
01/2021
1
Neutralizing Antibodies
IBA
01/2021
1
Clathrin
IBA
01/2021
1
rho-Associated Kinases
IBA
06/2020
1
rociletinib
IBA
05/2020
1
vorolanib
IBA
03/2020
1
CTLA-4 Antigen
IBA
01/2020
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2020
1
Antibodies
IBA
01/2020
1
Glucose Transporter Type 2
IBA
01/2020
1
Ubiquitin
IBA
01/2020
1
Granzymes (Granzyme)
IBA
01/2020
1
Cadherins (E-Cadherin)
IBA
01/2020
1
bcr-abl Fusion Proteins
IBA
01/2020
1
Ligases (Synthetase)
IBA
01/2020
1
Vimentin
IBA
01/2020
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2020
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2020
1
secalonic acid
IBA
05/2019
1
Member 2 Subfamily G ATP Binding Cassette Transporter
IBA
05/2019
1
conglobatin
IBA
01/2019
1
Mediator Complex
IBA
01/2019
1
mitochondrial calcium uniporter
IBA
01/2019
1
Carcinoembryonic Antigen
IBA
12/2018
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2018
1
Proteolysis Targeting Chimera
IBA
10/2018
1
olmutinib
IBA
07/2018
1
dacomitinib
IBA
02/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2018
1
RP4010
IBA
01/2018
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2018
1
NF-kappa B (NF-kB)
IBA
01/2018
1
Glucose (Dextrose)
FDA Link
Generic
11/2017
1
Peptides (Polypeptides)
IBA
11/2017
1
Arsenic Trioxide (Trisenox)
FDA Link
09/2017
1
abemaciclib
IBA
01/2017
1
Afatinib
IBA
01/2017
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
01/2017
1
alectinib
IBA
01/2017
Therapy/Procedure
24
Drug Therapy (Chemotherapy)
01/2024 - 04/2004
21
Therapeutics
03/2024 - 01/2010
6
Immunotherapy
03/2024 - 01/2021
3
Radiotherapy
01/2020 - 08/2015
2
Combination Drug Therapy (Combination Chemotherapy)
12/2015 - 12/2015
1
Time-to-Treatment
01/2023
1
Precision Medicine
01/2021